S1 E1 - Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A

S2 E1 - Enovis’ Vogt on driving recon growth past $1B w/ M&A, knee breakthroughs and foot & ankle expansion

In the kickoff episode of Season 2 of Ortho Innovation Talks, Louie Vogt, Group President of Reconstructive at Enovis, takes us inside the company’s strategic growth in orthopedics. Vogt shares how Enovis has transformed into a major player in the reconstructive space through key acquisitions and bold bets on innovative implant designs. He discusses the evolution of knee implants, highlighting Enovis’ pioneering work with kinematically driven bearings and the dual pivot knee concept. Vogt also touches on the growing role of robotics and enabling technologies in orthopedic surgery, emphasizing how these advancements are changing the surgeon experience and patient outcomes. Beyond knees, Vogt explores Enovis’ expansion into foot and ankle reconstruction—a rapidly growing market—and how the company is leveraging M&A and innovation to carve out a competitive edge. As Enovis looks ahead to 2025, Vogt teases major product launches in shoulders, hips, and extremities, signaling another big year for the company. This conversation comes to you courtesy of our sponsor, Paragon Medical. To learn more about how Paragon Medical can help you bring your device to market faster, visit them at www.paragonmedical.com [http://www.paragonmedical.com]. Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe [https://ortho-innovation-talks.castos.com/subscribe] + Follow us on YouTube.com/@DeviceTalks [https://www.youtube.com/@DeviceTalks] to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe [https://devicetalks.castos.com/subscribe]

S1 E3 - ZB’s Lancaster talks next-gen knee systems, robotics & building a new regional powerhouse

In this episode of Ortho Innovation Talks, Jim Lancaster, President of Global Reconstruction at Zimmer Biomet, connects his deep roots in Warsaw, Indiana—known as the orthopedic capital of the world—with his current role in shaping the region's future as a global MedTech hub with his efforts to diversify the region's medtech industry, including the partnership with Plug and Play to attract new innovations in sensor technology and augmented reality, and by driving technical innovations at Zimmer Biomet. Additionally, Lancaster provides an in-depth look at the development of Persona IQ, the world's first smart knee system, which integrates advanced sensor technology to monitor patient recovery. He also discusses the growing importance of cementless fixation in knee implants, highlighting Zimmer Biomet's focus on enhancing implant longevity and patient outcomes. Lastly, Lancaster discusses Zimmer Biomet's role in surgical robotics, particularly the advancements brought by the Rosa robotics platform, which includes applications for knee, hip, and even shoulder surgeries. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe [https://ortho-innovation-talks.castos.com/subscribe] + Follow us on YouTube.com/@DeviceTalks [https://www.youtube.com/@DeviceTalks] to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe [https://devicetalks.castos.com/subscribe]

S1 E2 - ZB’s Goyal on how passion for solving ortho challenges put him at the helm of R&D Engine

In this episode of Ortho Innovation Talks, Nitin Goyal, MD, chief science, technology and innovation officer at Zimmer Biomet (ZB) shares his journey from the OR to the medtech industry. Dr. Goyal oversees ZB’s global innovation, medical education, clinical affairs, and reimbursement strategy. He tells host Tom Salemi about his passion for building solutions to address clinical challenges and improve the surgical experience. Goyal’s own innovations landed him leadership positions at managed care powerhouse, UnitedHealthcare, followed by medtech giant, ZB. Goyal describes how his pursuit of “making an outsized impact” on orthopedic care brought him to ZB, where he leads the global innovation, medical education, and clinical affairs functions. In this talk, he’ll discuss how ZB incorporates smart implants that track and report mobility data, to big data analytics that guide clinical decision-making throughout the episode of care. Goyal explains why he believes we’re at an inflection point in orthopedics and how ZB intends to lead the way. Thank you to our episode sponsor, Millstone Medical for supporting this podcast. To learn more about Millstone Medical, please visit http://millstonemedical.com. [http://millstonemedical.com.] *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe [https://ortho-innovation-talks.castos.com/subscribe] + Follow us on YouTube.com/@DeviceTalks [https://www.youtube.com/@DeviceTalks] to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe [https://devicetalks.castos.com/subscribe]

S1 E1 - Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A

In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses. In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office. Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth. Thank you to our episode sponsor, AcuityMD for supporting this podcast. To learn more about AcuityMD, please visit http://acuitymd.com [http://acuitymd.com]. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe [https://ortho-innovation-talks.castos.com/subscribe] + Follow us on YouTube.com/@DeviceTalks [https://www.youtube.com/@DeviceTalks] to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe [https://devicetalks.castos.com/subscribe] Thank you for supporting Ortho Innovation Talks!